Why the study?
Long-term outcome across the three categories of acute coronary syndrome in real-life patient cohorts is not well known.
Key points are not available for this paper at this time.
Population
1188 consecutive patients with STEMI, NSTEMI, or UA admitted to a university hospital
Comparison
Outcomes compared across STEMI, NSTEMI, and UA categories
Design
Cohort study
Follow-up
≥ 10 years
High 10-year mortality persists across ACS subtypes in real-world cohorts; leaves open optimal long-term secondary prevention strategies.
BACKGROUND: Long-term outcome of the three categories of acute coronary syndrome (ACS) in real-life patient cohorts is not well known. The objective of this study was to survey the 10-year outcome of an ACS patient cohort admitted to a university hospital and to explore factors affecting the outcome. METHODS: A total of 1188 consecutive patients (median age 73 years) with ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI) or unstable angina pectoris (UA) in 2002-2003 were included and followed up for ≥ 10 years. RESULTS: Mortality for STEMI, NSTEMI and UA patients during the follow-up period was 52.5%, 69.9% and 41.0% (p < 0.001), respectively. In multivariable Cox regression analysis, only age and creatinine level at admission were independently associated with patient outcome in all the three ACS categories when analyzed separately. CONCLUSIONS: All the three ACS categories proved to have high mortality rates during long-term followup in a real-life patient cohort. NSTEMI patients had worse outcome than STEMI and UA patients during the whole follow-up period. Our study results indicate clear differences in the prognostic significance of various demographic and therapeutic parameters within the three ACS categories.
No takes yet. Share an insight, caveat, or question.
Konttila et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: